期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (5)
Objective This study aimed to clarify the expression of HLA-DQ and granulysin in peripheral blood T-cell subsets in patients with chronic hepatitis B ......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (9)
Alanine aminotransferase (ALT) flare remains one of the determinants of initiating antiviral therapy in children with chronic hepatitis B (CHB). Insuf......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (2)
Current therapeutic interventions can only suppress hepatitis B virus (HBV) replication or reduce complications without a cure. Therefore, further dev......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (8)
Hepatitis B virus (HBV) affects over 300 million people across the world and is further associated with the self-digesting process of autophagy. Accor......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (10)
Acute-on-chronic liver failure (ACLF) is a severe clinical syndrome associated with high short-term mortality and reversibility. This study aimed to c......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (9)
Combination therapy with pegylated interferon (PEG-IFN) and nucleos(t)ide analogues (NAs) can enhance hepatitis B surface antigen (HBsAg) clearance. H......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (6)
Alfosbuvir is a novel potent HCV NS5B polymerase inhibitor in development for the treatment of chronic HCV infection. Our previous studies indicated t......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (9)
Patients with chronic hepatitis C (CHC) have a higher prevalence of hepatic steatosis and dyslipidaemia than healthy individuals. We analysed noninvas......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (8)
To investigate the relationships between different hepatitis B virus (HBV) infection status and gestational diabetes mellitus (GDM) and analyse the po......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (5)
The study aimed to investigate the prevalence and risk factors associated with occult hepatitis B virus (HBV) infection (OBI) in the global population......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (3)
Liver steatosis is becoming increasingly common in patients with chronic hepatitis B (CHB), and its effect on liver stiffness measurement (LSM), as as......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (10)
This study aimed to evaluate the efficacy and safety of entecavir(ETV) versus ETV maleate in Chinese patients with chronic hepatitis B(CHB). This was ......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (5)
Patients with hepatitis B-related cirrhosis complicated with thrombocytopenia have a higher risk of bleeding, which may lead to higher mortality. We a......
期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (6)
The long-term impact, incidence and risk factors of thyroid dysfunction in chronic hepatitis B (CHB) patients receiving pegylated interferon (IFN) alp......
